Nuwellis
NUWE | NASDAQ
$4.62
-$0.28 (-5.71%)
At close: Nov 16, 2026, 3:59 PM ET
$4.63
+$0.01 (+0.22%)
After-hours:
Nov 16, 2026, 7:42 PM ET
Nuwellis Company Profile
Company profile explainedCompany Profile
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Key Executives
| Name | Position |
|---|---|
| Michael Kendrick McCormick | President, Chief Executive Officer & Director |
| David Lerner | Chief Technology Officer |
| Carisa Schultz | CFO, Principal Financial Officer & Principal Accounting Officer |
| Kim Anderson | Vice President, Research & Development, Quality and Operations |
| Leah McMullen | Director of Communications |
| Neil Ayotte | Senior Vice President, General Counsel, Secretary & Chief Compliance Officer |
| Paul Wotta | Corporate Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 23, 2026 | 8-K | Current Report |
| Sep 18, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 26, 2026 | EFFECT | Filing |
| Aug 26, 2026 | 424B3 | Filing |
| Aug 26, 2026 | 8-K | Current Report |
| Aug 18, 2026 | S-3 | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2026 | 8-K | Current Report |
| Aug 13, 2026 | 10-Q | Quarterly Report |
| Aug 07, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nuwellis
| Country | United States |
| IPO Date | Feb 16, 2012 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 38 |
| CEO | Michael McCormick |
Contact Details
12988 Valley View Road Eden Prairie,
Minnesota 55344 United States
Stock Details
| Ticker Symbol | NUWE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001506492 |
| CUSIP Number | 67113Y884 |
| ISIN Number | US67113Y8848 |
| SIC Code | 3845 |
Recent News
- 21 days ago / globenewswire.comNuwellis Announces Acceptance of Multicenter Pediatric Aquadex Study in Pediatric Nephrology
- 1 month ago / globenewswire.comNuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System
- 2 months ago / globenewswire.comNuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences
- 2 months ago / globenewswire.comNuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity
- 2 months ago / globenewswire.comNuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs
- 2 months ago / globenewswire.comNuwellis Advances Financial Efficiency Strategy with Improved Gross Margins
- 3 months ago / globenewswire.comNuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical
- 3 months ago / seekingalpha.comNuwellis, Inc. (NUWE) Q2 2026 Earnings Call Prepared Remarks Transcript
Add to Watchlist
Select watchlists to add or remove NUWE